Why is Phaarmasia falling/rising?

As of 26-Sep, Phaarmasia Ltd's stock price is currently at 35.21, reflecting a decline of 1.06, or 2.92%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 7.44%. Despite opening the day with a gain of 4.96% and reaching an intraday high of Rs 38.07, it has struggled to maintain momentum, touching a low of Rs 35.04. Over the past week, the stock has seen a significant decline of 14.54%, while its year-to-date performance shows a stark drop of 27.40%. The company has reported weak long-term fundamental strength, with a -213.21% CAGR growth in operating profits over the last five years and negative EBITDA, contributing to its recent price movement.
In the broader market context, Phaarmasia's performance has been notably worse than the benchmark, with the Sensex declining only 2.66% over the same week. The pharmaceutical sector has also faced challenges, falling by 2.35%. Despite a rise in investor participation, as indicated by a 151.48% increase in delivery volume, the overall sentiment remains negative due to the company's reported losses and poor financial ratios, such as a negative EBIT to interest ratio of -1.57. This combination of weak fundamentals and sector-wide declines has led to Phaarmasia's continued underperformance in the market.